MAP3K14 antibody [N1N2], N-term
Not tested in other applications.
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||104 kDa (note)
|Positive Controls||A431 , H1299 , HeLa , HepG2 , Molt-4 , Raji|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by antigen-affinity chromatography.|
|Full Name||mitogen-activated protein kinase kinase kinase 14|
|Product Description||Rabbit Polyclonal antibody to MAP3K14 (mitogen-activated protein kinase kinase kinase 14)|
|Background||This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq]|
|Synonyms||FTDCR1B antibody, HS antibody, HSNIK antibody, NIK antibody, MAP3K14 antibody, NF-kappa-beta-inducing kinase antibody, serine/threonine protein-kinase antibody, mitogen-activated protein kinase kinase kinase 14 antibody, serine/threonine-protein kinase NIK antibody|
|Immunogen||Recombinant protein encompassing a sequence within the N-terminus region of human MAP3K14. The exact sequence is proprietary.|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Mouse, Rat, Rhesus Monkey, Bovine|
|Predict Reactivity Note||Mouse (91%), Rat (93%), Rhesus Monkey (100%), Bovine (95%)|